Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
11/08/2006 | CN1857740A Tumor model and method |
11/08/2006 | CN1857739A Tumor model and method |
11/08/2006 | CN1283320C Liver specificity CT contrast medium and its preparation method |
11/07/2006 | US7132234 or drug targets; contacting a poxviral p28 polypeptide with a candidate agent, and determining an effect on ubiquitin ligase activity of the p28; ubiquitylating a substrate by combining an E1 polypeptide, an E2 polypeptide, ubiquitin and a poxvirus P28 protein; variola virus (smallpox) drug discovery |
11/07/2006 | US7132096 Inhibiting enoyl reductase; altering pathway of fatty acid synthesis; screening |
11/07/2006 | CA2130703C Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them |
11/07/2006 | CA2091967C Monoclonal anti-ganglioside antibody, its preparation and use as a tumor therapeutic agent |
11/02/2006 | WO2006116742A2 Fluorescent nanoparticles conjugated to antibodies via a peg linker |
11/02/2006 | WO2006116721A1 Ex vivo gene expression in whole blood as a model of assessment of individual variation to dietary supplements |
11/02/2006 | WO2006116538A2 Medical device with a marker |
11/02/2006 | WO2006116403A2 Intracellular thermal ablation using nano-particle electron spin resonance heating |
11/02/2006 | WO2006116083A2 The 1, 5-anhydroglucitol (1, 5-ag) assay and a1c/1. 5-ag assay combination for measuring blood glucose excursions in general and postprandial hyperglycemia in diabetic patients |
11/02/2006 | WO2006116021A2 Mri technique based on electron spin resonance and endohedral contrast agent |
11/02/2006 | WO2006115416A2 Liposomes |
11/02/2006 | WO2006115155A1 Liposome-containing preparation and process for producing the same |
11/02/2006 | WO2006114286A2 Production of albumin-fluorescein conjugates for use in intraoperative diagnosis |
11/02/2006 | WO2006084257A3 Steady state perfusion methods |
11/02/2006 | WO2006072948A3 Gastro-retentive diagnostic assemblies |
11/02/2006 | WO2006039663A3 Methods for the administration of iloperidone |
11/02/2006 | WO2004032711A3 Diagnosis and monitoring of inflammation, ischemia and appendicitis |
11/02/2006 | US20060246085 Methods for manipulating satiety |
11/02/2006 | US20060246039 Growth differentiation factor-7 |
11/02/2006 | US20060246006 CD39L3 and its role in diabetes |
11/02/2006 | EP1716871A2 Diagnostic imaging contrast agents with extended blood retention |
11/02/2006 | EP1716870A1 MRI contrast agents endowed with concentration independent responsiveness |
11/02/2006 | EP1716426A1 Method for the hyperpolarisation of atomic nuclei and device for carrying out said method |
11/02/2006 | EP1715897A2 High frequency ultrasound imaging using contrast agents |
11/02/2006 | EP1715870A1 Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure |
11/02/2006 | EP1467761B1 Treatment of neovascular ophthalmic disease |
11/02/2006 | EP1223925B1 Fatty acid derivative for the treatment of external secretion disorders |
11/02/2006 | CA2606018A1 Nanoparticle conjugates |
11/01/2006 | CN1856547A Fluorinated dyes or colorants and their uses |
11/01/2006 | CN1854157A Antibodies to insulin-like growth factor i receptor |
11/01/2006 | CN1854122A Blood pool agents for nuclear magnetic resonance diagnostics |
11/01/2006 | CN1853732A Matrix metalloproteinase inhibitors as target component in diagnose agent |
11/01/2006 | CN1853730A Modified cytokines for use in cancer therapy |
10/31/2006 | US7129222 Immunomodulatory formulations and methods for use thereof |
10/31/2006 | US7129219 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group |
10/31/2006 | US7128896 using carbocyanine dyes; photodynamic therapy; in vivo supplying to tumor |
10/31/2006 | US7128895 Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability |
10/31/2006 | US7128894 Contrast enhancing solution for use in confocal microscopy |
10/31/2006 | US7128893 Used to target radionuclides to cells, such as a variety of tumor cell types, for use in diagnostic imaging; peptide derivatives of vitamins such as folate, riboflavin, thiamine, vitamin B12, and biotin chelated to a radionuclide |
10/26/2006 | WO2006113237A2 Cd39l3 and its role in diabetes |
10/26/2006 | WO2006112443A1 Novel method of using triacetin and auxiliary agent for ultrasonic diagnostic examination |
10/26/2006 | WO2006076343A8 Mycobacteria expressing hiv-1 and malaria antigens |
10/26/2006 | WO2002101008A3 Intracellular signaling molecules |
10/26/2006 | US20060241466 Hollow microspheres with controlled fragility for medical use |
10/26/2006 | US20060241170 Methods and formulations of taxanes |
10/26/2006 | US20060240064 Medical implants and fibrosis-inducing agents |
10/26/2006 | US20060240063 Medical implants and fibrosis-inducing agents |
10/26/2006 | US20060240004 Methods for treating tweak-related conditions |
10/26/2006 | US20060239926 Specific high-relaxivity compounds |
10/26/2006 | US20060239925 Method of manufacturing pharmaceutical preparation containing liposomes |
10/26/2006 | US20060239924 Carrier with a metal binding domain, a metal ion, and an active agent; e.g., polylysine with a polyoxyethylene side chain with a polyalkylenepolyaminepolyacetic acid bonded to a transition metal ion bonded to a protein or nucleotide; drug delivery |
10/26/2006 | US20060239923 Gastrin releasing peptide compounds |
10/26/2006 | US20060239922 Water-soluble fluoro-substituted cyanine dyes as reactive fluorescence labelling reagents |
10/26/2006 | US20060239921 Real time vascular imaging during solid organ transplant |
10/26/2006 | US20060239914 bombesin, derivatives and/or analogues capable of complexing metal ions, radionuclides or optical labels, for use in radiotherapy |
10/26/2006 | US20060239913 Peptide conjugate for magnetic resonance imaging |
10/26/2006 | US20060239912 Carrier molecules |
10/26/2006 | DE102005019452A1 New 18-fluorine-substituted 3'-deoxythymidine derivatives, useful in positron emission tomography, particularly for detection of brain tumors |
10/26/2006 | DE102005019104A1 New conjugate of fluorescent dye bonded directly to protein, useful for intraoperative representation of tumors, inflammation and lymph nodes |
10/26/2006 | CA2604675A1 Diagnostic and therapeutic potential of immune globulin intravenous (igiv) products |
10/25/2006 | EP1713935A1 Modulation of hsv infection |
10/25/2006 | EP1713821A2 Primary central nervous system tumor specific behab isoforms |
10/25/2006 | EP1713514A2 Drugs and gene carrier particles that rapidly move through mucous barriers |
10/25/2006 | EP1713513A2 Cellular labeling for nuclear magnetic resonance techniques |
10/25/2006 | EP1713512A2 Contrast agents for myocardial perfusion imaging |
10/25/2006 | EP1713499A1 Methods and compounds for modulating triglyceride and vldl secretion |
10/25/2006 | EP1713457A2 Novel drugs and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases |
10/25/2006 | EP1558293A4 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body |
10/25/2006 | EP1534990B1 Automated dynamic pressure-responsive hyperpolarized gas dispensing systems, and associated methods and computer program products |
10/25/2006 | EP1487334A4 Paramagnetic particles that provide improved relaxivity |
10/25/2006 | EP1420880A4 Stabilization and terminal sterilization of phospholipid formulations |
10/25/2006 | EP1135170B1 Radioconjugation of internalizing antibodies |
10/25/2006 | EP1109901B1 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF |
10/25/2006 | EP0977599B1 Contrast agents comprising an azeotropic mixture of two gases for ultrasound investigations |
10/25/2006 | CN1852728A Host defense factor X (HDFX) |
10/25/2006 | CN1281278C Gene-carrying micro-bublle of target transfergene, its preparation method and use |
10/24/2006 | US7126004 Thiazoline acid derivatives |
10/24/2006 | US7125965 an spiro(1-benzopyran-2,2'-indole) indicator coupled to a lanthanide-chelated DO3A macrocycle; conformational changes of the indicator affect the interaction of the bound lanthanide with water |
10/24/2006 | US7125860 Cross-linked derivatives of hyaluronic acid |
10/24/2006 | US7125683 Preparations for diagnosis extrapancreatic secretory function |
10/24/2006 | US7125541 Administering targeting agent operatively attached to a therapeutic agent, and wherein the targeting agent recognizes and binds to a tumor-associated endothelial cell marker |
10/24/2006 | CA2273549C Diagnostic agents for pancreatic exocrine function |
10/24/2006 | CA2212744C Microcapsules of predetermined peptide(s) specificity(ies), their preparation and uses |
10/19/2006 | WO2006110172A2 Steroid analogs and characterization and treatment methods |
10/19/2006 | WO2005094327A9 Isolation of epithelial cells or their biochemical contents from excreta after in vivo isotopic labeling |
10/19/2006 | US20060235312 Combination and method including a visual marker for determining compliance with a medication regimen |
10/19/2006 | US20060235296 Contrast enhanced x-ray phase imaging |
10/19/2006 | US20060235292 Magnetic resonance imaging method and compounds for use in the method |
10/19/2006 | US20060235193 Biocompatible materials and probes |
10/19/2006 | US20060234909 Compositions and methods for increasing drug efficiency |
10/19/2006 | US20060234317 Method of screening |
10/19/2006 | US20060233794 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
10/19/2006 | US20060233754 A kit containing a compound promoting delivery of exogenous genes to cells, e.g., 1-(5-chloro-2-hydroxyphenyl)-3-(3-pyridinyl)-1,3-propanedione; 1-Tetradecylarsonic acid; N1-(2-fluoro-9-acridinyl)-N3N3-dimethyl-1,3-propanediamine; and N4(bis(2-chloroethy)amino)benzylidene)1,3-thiazol-2-amine |
10/19/2006 | US20060233713 Gadolinium particle-based MRI contrast agents |
10/19/2006 | US20060233712 Magnetic nanoparticles |
10/19/2006 | US20060233711 Method for treating conditions associated with fear memory |
10/19/2006 | US20060233710 Prevention and treatment for GVHD |